Alnylam Pharmaceuticals has published data on the use of combinations of novel lipid materials to systemically deliver RNAi therapeutics.
The work was conducted by Alnylam researchers in collaboration with scientists at the Massachusetts Institute of Technology (GSN 5/10/2007), and appeared in Molecular Therapy.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.
In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.
Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.
Broken links are found throughout academic publications, and some services are trying to combat such link decay.